BioMarin Pharmaceutical
BMRN
#1731
Rank
A$17.67 B
Marketcap
A$91.27
Share price
-1.64%
Change (1 day)
11.99%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): A$62.57 Million

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$3.65 Billion. In 2025 the company made an earning of A$0.72 Billion a decrease over its 2024 earnings that were of A$0.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$62.57 M-91.42%
2025 A$0.72 B-10.94%
2024 A$0.81 B187.31%
2023 A$0.28 B26.07%
2022 A$0.22 B-298.51%
2021 -A$0.12 Billion78.04%
2020 -A$63.95 Million-55.36%
2019 -A$0.15 Billion-33.56%
2018 -A$0.22 Billion297.78%
2017 -A$54.2 Million-95.68%
2016 -A$1.26 Billion437.12%
2015 -A$0.24 Billion23.91%
2014 -A$0.19 Billion-29.25%
2013 -A$0.27 Billion49.23%
2012 -A$0.18 Billion171.11%
2011 -A$65.92 Million103.01%
2010 -A$32.47 Million-3903.54%
2009 A$0.85 M-98.31%
2008 A$50.49 M-189.7%
2007 -A$56.3 Million51.02%
2006 -A$37.28 Million-61.58%
2005 -A$97.02 Million-56.59%
2004 -A$0.23 Billion95.13%
2003 -A$0.12 Billion12.09%
2002 -A$0.11 Billion73.19%
2001 -A$59 Million18.32%
2000 -A$49.86 Million19.65%
1999 -A$41.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
A$11.76 B 17,735.86%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.68 Billion-1,124.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B 81.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.28 M-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.44 B 578.94%๐Ÿ‡บ๐Ÿ‡ธ USA